US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agenus

2.08

+0.430026.06%

Pre-market: 1.90-0.1800-8.65%05:56 EDT

Volume:704.47K

Turnover:1.38M

Market Cap:52.64M

PE:-0.20

High:2.12

Open:1.65

Low:1.65

Close:1.65

Loading ...

Overview Company News Filings

Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025

Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges

Agenus (AGEN) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing

William Blair Sticks to Its Hold Rating for Agenus (AGEN)

Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates

Agenus: Q4 Earnings Snapshot

Associated Press Finance

Agenus Q4 2024 GAAP EPS $(2.04) Beats $(2.54) Estimate, Sales $26.84M Miss $30.27M Estimate

Agenus reports Q4 EPS ($2.04), consensus ($2.54)

Press Release: Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program

Calendar of U.S. Earnings Expected in the Week Ahead

Agenus Inc expected to post a loss of $2.54 a share - Earnings Preview

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications

Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

THOMSON REUTERS

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting

Incyte terminates license agreement with Agenus

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AGEN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","market":"US","secType":"STK","nameCN":"Agenus","latestPrice":2.08,"timestamp":1744920000000,"preClose":1.65,"halted":0,"volume":704471,"hourTrading":{"tag":"盘前","latestPrice":1.9,"preClose":2.08,"latestTime":"05:56 EDT","volume":1,"amount":1.9,"timestamp":1745229400238},"delay":0,"floatShares":24692942,"shares":25308841,"eps":-10.5913,"marketStatus":"Pre-Mkt","change":0.43,"latestTime":"04-21 07:10:20 EDT","open":1.65,"high":2.1192,"low":1.65,"amount":1375123.869645,"amplitude":0.284364,"askPrice":2.01,"askSize":687,"bidPrice":1.93,"bidSize":229,"shortable":3,"etf":0,"ttmEps":-10.5913,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745242200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":949640400000,"exchange":"NASDAQ","adjPreClose":2.08,"preHourTrading":{"tag":"盘前","latestPrice":1.9,"preClose":2.08,"latestTime":"05:56 EDT","volume":1,"amount":1.9,"timestamp":1745229400238},"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.08,"latestTime":"19:58 EDT","volume":10836,"amount":22734.8827,"timestamp":1744934335901},"volumeRatio":2.1817477173243627,"impliedVol":1.6293,"impliedVolPercentile":0.7269},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","floatShares":24692942,"roa":"-28.79%","roe":"-1278.83%","lyrEps":-10.5913,"volumeRatio":2.1817477173243627,"shares":25308841,"dividePrice":0,"high":2.1192,"amplitude":0.284364,"preClose":1.65,"low":1.65,"week52Low":1.38,"pbRate":"-0.16","psRate":"0.51","week52High":19.688,"institutionHeld":0.042,"latestPrice":2.08,"committee":-0.5,"eps":-10.5913,"divideRate":0,"volume":704471,"delay":0,"ttmEps":-10.5913,"open":1.65,"prevYearClose":2.74,"prevWeekClose":2.08,"prevMonthClose":1.505,"prevQuarterClose":1.505,"fiveDayClose":1.62,"twentyDayClose":1.67,"sixtyDayClose":3.66},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGEN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522838780","title":"Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522838780","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522838780?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:40","pubTimestamp":1742935200,"startTime":"0","endTime":"0","summary":"First oral presentation of BOT/BAL neoadjuvant results from the NEOASIS trial in MSI-H and MSS solid tumors. New data from the treatment-refractory hepatocellular carcinoma  cohort of the BOT/BAL Phase 1 trial to be presented. LEXINGTON, Mass., March 25, 2025----Agenus Inc. , a leader in immuno-oncology, today announced two upcoming presentations at the American Association for Cancer Research  Annual Meeting, taking place April 25–30, 2025 in Chicago, Illinois. The presentations continue to build momentum for Agenus’ neoadjuvant immunotherapy program with botensilimab and balstilimab , including an oral presentation of the initial results from the NEOASIS trial in solid tumors and a poster featuring new data from the advanced hepatocellular carcinoma  cohort of a Phase 1 study evaluating BOT/BAL in patients with advanced solid tumors. Data from two separate, independent studies of neoadjuvant treatment with BOT/BAL in colorectal cancer--UNICORN and NEST-- were presented earlier this y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-present-bot-bal-data-204000586.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AGEN","BK4006","BAL","HCC"],"gpt_icon":0},{"id":"2518558200","title":"Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2518558200","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518558200?lang=en_us&edition=fundamental","pubTime":"2025-03-12 15:03","pubTimestamp":1741763025,"startTime":"0","endTime":"0","summary":"Cash Balance: Ended 2024 with $40.4 million, down from $76.1 million at the end of 2023.Cash Used in Operations: $158 million for the year ended December 31, 2024, reduced from $224 million in the prior year.Annual Revenue: $103.5 million for the year ended December 31, 2024.Net Loss: $232.3 million or $10.59 per share for the year ended December 31, 2024.Quarterly Revenue: $26.8 million for the fourth quarter ended December 31, 2024.Quarterly Net Loss: $46.8 million or $2.04 per share for the fourth quarter ended December 31, 2024.Operational Burn Rate: Reduced to approximately $50 million annualized by mid-2025.GuruFocus has detected 4 Warning Signs with AGEN.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Agenus Inc  successfully reduced its annualized operational burn rate, aligning with its financial guidance.A: Garo Armen, CEO, stated that the first stage of monetization involved a $20 million mortgage on West Coast assets. Disc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-inc-agen-q4-2024-070345058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AGEN"],"gpt_icon":0},{"id":"2518726742","title":"Agenus (AGEN) Q4 2024 Earnings Call Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2518726742","media":"Motley Fool Transcribing","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518726742?lang=en_us&edition=fundamental","pubTime":"2025-03-11 23:45","pubTimestamp":1741707916,"startTime":"0","endTime":"0","summary":"AGEN earnings call for the period ending December 31, 2024.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2025/03/11/agenus-agen-q4-2024-earnings-call-transcript/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["AGEN"],"gpt_icon":0},{"id":"2518972649","title":"William Blair Sticks to Its Hold Rating for Agenus (AGEN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518972649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518972649?lang=en_us&edition=fundamental","pubTime":"2025-03-11 23:25","pubTimestamp":1741706728,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps maintained a Hold rating on Agenus (AGEN – Research Report) today. The company’s shares opened today at $2.29. Ph...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-its-hold-rating-for-agenus-agen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-its-hold-rating-for-agenus-agen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN"],"gpt_icon":0},{"id":"2518108725","title":"Agenus (AGEN) Reports Q4 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2518108725","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518108725?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:40","pubTimestamp":1741696804,"startTime":"0","endTime":"0","summary":"Agenus  came out with a quarterly loss of $2.04 per share versus the Zacks Consensus Estimate of a loss of $2.36. This compares to loss of $2.60 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 13.56%. A quarter ago, it was expected that this biotechnology company would post a loss of $2.10 per share when it actually produced a loss of $3.17, delivering a surprise of -50.95%.Agenus , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $26.84 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 20.21%. This compares to year-ago revenues of $83.8 million. The company has not been able to beat consensus revenue estimates over the last four quarters.Agenus shares have lost about 21.5% since the beginning of the year versus the S&P 500's decline of -4.5%.While Agenus has underperformed the market so far this year, the question that comes to i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-agen-reports-q4-loss-124004669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AGEN"],"gpt_icon":0},{"id":"2518874341","title":"Agenus: Q4 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2518874341","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518874341?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:43","pubTimestamp":1741693413,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass.  — LEXINGTON, Mass.  — Agenus Inc.  on Tuesday reported a loss of $46.8 million in its fourth quarter.The Lexington, Massachusetts-based company said it had a loss of $2.04 per share.The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $2.36 per share.The biotechnology company posted revenue of $26.8 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $33.6 million.For the year, the company reported that its loss narrowed to $232.3 million, or $10.59 per share. Revenue was reported as $103.5 million.The company's shares closed at $2.15. A year ago, they were trading at $13.40.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-q4-earnings-snapshot-114333173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AGEN"],"gpt_icon":0},{"id":"2518671701","title":"Agenus Q4 2024 GAAP EPS $(2.04) Beats $(2.54) Estimate, Sales $26.84M Miss $30.27M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2518671701","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518671701?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:39","pubTimestamp":1741693187,"startTime":"0","endTime":"0","summary":"Agenus (NASDAQ:AGEN) reported quarterly losses of $(2.04) per share which beat the analyst consensus estimate of $(2.54) by 19.69 percent. This is a 21.54 percent increase over losses of $(2.60) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44243587/agenus-q4-2024-gaap-eps-2-04-beats-2-54-estimate-sales-26-84m-miss-30-27m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Agenus Q4 2024 GAAP EPS $(2.04) Beats $(2.54) Estimate, Sales $26.84M Miss $30.27M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN"],"gpt_icon":0},{"id":"2518874860","title":"Agenus reports Q4 EPS ($2.04), consensus ($2.54)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518874860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518874860?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:35","pubTimestamp":1741692945,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $26.84M, consensus $30.09M. “In line with our strategic objectives, we significantly reduced our annualized operational burn rat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agenus-reports-q4-eps-2-04-consensus-2-54?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agenus-reports-q4-eps-2-04-consensus-2-54?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN"],"gpt_icon":0},{"id":"2518717464","title":"Press Release: Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2518717464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518717464?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:30","pubTimestamp":1741692600,"startTime":"0","endTime":"0","summary":"Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program. Agenus Inc.  , an immuno-oncology company advancing innovative cancer therapies, today reported financial and operational results for Q4 and full-year 2024, highlighting strategic measures to substantially reduce operational costs while preserving and enhancing the potential of its leading BOT/BAL program.\"In line with our strategic objectives, we significantly reduced our annualized operational burn rate. We anticipate further reducing our annual burn to an annualized rate of approximately $50 million by mid-2025 through the externalization of development costs associated with BOT/BAL, monetization of our CMC assets, and other reductions in operating expenses,\" stated Garo Armen, Ph.D., Chairman and CEO of Agenus. \"These steps reflect our commitment to prioritizing resources for BOT/BAL-- our most promising clinical asset-","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN","BAL"],"gpt_icon":0},{"id":"2518471593","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2518471593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518471593?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:00","pubTimestamp":1741687200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Allbirds Inc. Class A                           4Q       4:05 PM. ·Dick's Sporting Gds                              4Q      3.52   7:00 AM. ·E. W. Scripps Co                                 4Q      1.01       AMC. ·European Wax Ctr                                4Q       .06   6:00 AM. ·First Watch Rest                                4Q       .01   7:00 AM. ·Kanzhun Ltd. Sp ADR                               4Q       .22       BMO","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATLC","UNFI","NOA","SMSI","RMBL","WEST","ASRT","BW","KSS","LRMR","BWAY","WSM","AGEN","MNTK","SKIN","KRMD","SPRB","ARCO","DRUG","SSP","ABM","EWCZ","AKBA","FTCI","SID","PHLT","BLDE","APYX","KALV","S","AFCG","KFY","MGTX","BIRD","HLLY","QRHC","VTS","TH","BTMD","ACHV","DKS","EBR","ZYXI","BZ","BBCP","SKYX","ONDS","EXK","LEGN"],"gpt_icon":1},{"id":"2517385544","title":"Agenus Inc  expected to post a loss of $2.54 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517385544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517385544?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:28","pubTimestamp":1741354089,"startTime":"0","endTime":"0","summary":"Agenus Inc  expected to post a loss of $2.54 a share - Earnings Preview Agenus Inc AGEN.OQ AGEN.O is expected to show a fall in quarterly revenue when it reports  results on March 11 for the period en","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ16K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN"],"gpt_icon":0},{"id":"2514892705","title":"Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514892705","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514892705?lang=en_us&edition=fundamental","pubTime":"2025-02-27 06:35","pubTimestamp":1740609307,"startTime":"0","endTime":"0","summary":"Kura Oncology  came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $0.55 per share a year ago. These figures are adjusted for non-recurring items.Kura Oncology , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $53.88 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 76.49%. This compares to zero revenues a year ago.Kura Oncology shares have lost about 9.5% since the beginning of the year versus the S&P 500's gain of 1.3%.While Kura Oncology has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 24% of the 250 plus Zacks industries. Ou","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kura-oncology-kura-reports-q4-223507596.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AGEN","KURA"],"gpt_icon":0},{"id":"2514895520","title":"Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications","url":"https://stock-news.laohu8.com/highlight/detail?id=2514895520","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514895520?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:48","pubTimestamp":1740606480,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., February 26, 2025----Agenus Inc. , a leader in immuno-oncology innovation, today highlights key scientific contributions in 2024-2025 that are shaping the future of cancer immunotherapy.Agenus is advancing a robust clinical pipeline targeting complementary mechanisms to fight cancer, including checkpoint inhibitors, immune activators, tumor microenvironment conditioning agents and cell therapies . Our most advanced antibody candidates, botensilimab  an Fc-enhanced CTLA-4 blocking antibody, and balstilimab , a novel, PD-1 inhibitor, are central to our efforts.BOT is currently being investigated as a monotherapy and in combination with widely used standard of care anti-PD-1, chemotherapy, and allogeneic cell therapy across multiple indications:. Dr. O’Day continues, \"By leveraging our deep expertise in immune activation, we are unlocking responses in tumors previously resistant to immunotherapy. The results are even more promising as we move from treatment refractory me","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-reports-impact-key-immuno-214800977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4113","BK4139","BK4022","BK4213","CRC","OS","LU0266512127.USD","BK4097","MSS","PFS","BAL","BK4232","BK4195","BK4211","R","AGEN","LU0456854461.SGD","ORR"],"gpt_icon":0},{"id":"2514004371","title":"Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2514004371","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514004371?lang=en_us&edition=fundamental","pubTime":"2025-02-26 03:30","pubTimestamp":1740511800,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., February 25, 2025----Agenus Inc. , a leader in immuno-oncology, today announced participation in a panel discussion at the B. Riley Securities Precision Oncology & Radiopharma Investor Conference that will take place on Friday, February 28th in New York.This event is for in-person participants only. Contact B. Riley for information on attending the conference.Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies  and adjuvants . Agenus has robust end-to-end development capabilities, across commercial and clinical cGMP manufacturing facilities, research and discovery, and a global clinical operations footprint. Agenus is headquartered in Lexington, MA. For more information, visit www.agenusb","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-participate-b-riley-securities-193000648.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZL793.SGD","IE00B19Z4B17.USD","BK4139","BK4127","IE0031619046.USD","AGEN","IE00B66KJ199.SGD","RILY"],"gpt_icon":0},{"id":"2514091804","title":"Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091804?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:26","pubTimestamp":1740489960,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nTUA8F2NBL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2514091069","title":"Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2514091069","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514091069?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:26","pubTimestamp":1740489960,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., February 25, 2025----Agenus Inc.  , a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its fourth quarter and year end 2024 financial results before the market opens on Tuesday, March 11th. Agenus executives will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and provide a corporate update.Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies  and adjuvants . Agenus has robust end-to-end development capabilities, across commercial and clinical cGMP manufacturing facilities, research and discovery, and a global clinical operations footprint. Agenus is headquartered in Lexington, MA. For ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-corporate-fourth-quarter-full-132600656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AGEN"],"gpt_icon":0},{"id":"2513729087","title":"Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2513729087","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513729087?lang=en_us&edition=fundamental","pubTime":"2025-02-24 21:33","pubTimestamp":1740403980,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., February 24, 2025----Agenus Inc. , a leader in immuno-oncology, today presented data at the American Association for Cancer Research  IO Annual Meeting in Los Angeles, California. The oral presentation highlights translational data from the ongoing Phase 2 study evaluating botensilimab  and balstilimab  in combination with MiNK Therapeutics’ agenT-797, an allogeneic invariant natural killer T  cell therapy, in patients with refractory (2L+) gastric cancer .\"These latest data demonstrate the remarkable potential of combining BOT/BAL with a novel iNKT cell therapy to broaden and intensify immune responses against resistant gastric tumors,\" said Dr. Dhan Chand, Vice President of Research at Agenus. \"By driving strong IFNγ production, deep T-cell infiltration, and memory T-cell activation—even in PD-1–refractory patients—the addition of agenT-797 to BOT/BAL could redefine what’s possible in late-line gastric cancer. We’re particularly encouraged by how these therapies wor","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-presents-botensilimab-balstilimab-data-133300379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BAL","AGEN","BK4139"],"gpt_icon":0},{"id":"2513292008","title":"Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2513292008","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513292008?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:40","pubTimestamp":1740148811,"startTime":"0","endTime":"0","summary":"The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Agenus  been one of those stocks this year?By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Agenus is one of 1010 individual stocks in the Medical sector. Collectively, these companies sit at #2 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Agenus is currently sporting a Zacks Rank of #2 .Over the past three months, ANIXA BIOSCIENCES INC's consensus EPS estimate for the current ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-agen-stock-outpacing-medical-144011188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ANIX","AGEN","BK4139"],"gpt_icon":0},{"id":"2511227583","title":"Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2511227583","media":"Business Wire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511227583?lang=en_us&edition=fundamental","pubTime":"2025-02-13 02:00","pubTimestamp":1739383200,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., February 12, 2025----Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research  IO Annual Meeting that will take place on February 23-26 in Los Angeles, California. An oral presentation will highlight interim data from the ongoing Phase 2 study of botensilimab and balstilimab  in combination with MiNK Therapeutics’ iNKT cell therapy, AgenT-797, in patients with refractory (2L+) gastric cancer . A Trial-in-Progress  poster will feature data from the ongoing Phase 1/2 study of BOT/BAL in first-line MSS colorectal cancer .Abstract Title: First-line botensilimab and balstilimab optimization in microsatellite stable colorectal cancer  without liver metastasis . Session Date and Time: Monday, February 24th, 1:45-4:45 p.m. PST. Session Date and Time: Tuesday, February 25th, 1:00-1:45 p.m. PST. Botensilimab  is a human Fc enhanced CTLA-4 blocking antibody designed to b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agenus-bot-bal-selected-two-180000744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BAL","BK4179","IO","BK4139","AGEN"],"gpt_icon":0},{"id":"2510811214","title":"Incyte terminates license agreement with Agenus","url":"https://stock-news.laohu8.com/highlight/detail?id=2510811214","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510811214?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:55","pubTimestamp":1739228106,"startTime":"0","endTime":"0","summary":"In January 2015, Agenus (AGEN) entered into a License, Development, and Commercialization Agreement with Incyte (INCY), under which Incyte licensed...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/incyte-terminates-license-agreement-with-agenus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/incyte-terminates-license-agreement-with-agenus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4532","BK4588","INCY","BK4585","AGEN","BK4550"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-11","symbol":"AGEN","fiscalQuarterEnding":"2024/12","expectedEps":-2.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-2.04},{"market":"US","date":"2024-11-12","symbol":"AGEN","fiscalQuarterEnding":"2024/09","expectedEps":-2.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-3.17},{"market":"US","date":"2024-08-08","symbol":"AGEN","fiscalQuarterEnding":"2024/06","expectedEps":-1.33,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-2.52},{"market":"US","date":"2024-05-07","symbol":"AGEN","fiscalQuarterEnding":"2024/03","expectedEps":-3.58,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":-3.04},{"market":"US","date":"2024-04-12","symbol":"AGEN","defaultRemindTime":1712928600000,"type":"split","dateTimestamp":1712894400000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGEN\",market:\"US\",,,undefined,":[{"executeDate":"2023-04-26","recordDate":"2023-04-17","paymentDate":"2023-05-01","value":0.0146,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.2,"hold":0.8,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.8,"analysts":5,"updateTime":1721448000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGEN","date":"2025-04-17","current":-0.183791,"percent":0.876238,"low":-44.01113,"twenty":-4.758834,"median":-2.484485,"eighty":-0.381387,"high":287.304865,"avg":9.68829,"sd":50.919375,"marketCap":41759587},"quantilePoints":[{"date":"2020-04-24","current":-4.187706,"twenty":-11.20977,"median":-4.014727,"eighty":-2.967434,"marketCap":450835887},{"date":"2020-05-01","current":-3.824784,"twenty":-10.955179,"median":-4.010647,"eighty":-2.967434,"marketCap":411764731},{"date":"2020-05-08","current":-2.478864,"twenty":-9.609351,"median":-4.007357,"eighty":-2.953828,"marketCap":423481613},{"date":"2020-05-15","current":-2.36523,"twenty":-7.421967,"median":-3.998464,"eighty":-2.91004,"marketCap":404068822},{"date":"2020-05-22","current":-2.484485,"twenty":-6.845337,"median":-3.973637,"eighty":-2.881369,"marketCap":424442040},{"date":"2020-05-29","current":-3.706852,"twenty":-6.782536,"median":-3.963092,"eighty":-2.836115,"marketCap":633267523},{"date":"2020-06-05","current":-3.826108,"twenty":-6.714093,"median":-3.953625,"eighty":-2.836115,"marketCap":653640741},{"date":"2020-06-12","current":-3.468342,"twenty":-6.677479,"median":-3.94731,"eighty":-2.836115,"marketCap":592521087},{"date":"2020-06-19","current":-3.806232,"twenty":-6.598515,"median":-3.928728,"eighty":-2.836115,"marketCap":650245205},{"date":"2020-06-26","current":-3.945363,"twenty":-6.443629,"median":-3.928728,"eighty":-2.836115,"marketCap":674013959},{"date":"2020-07-02","current":-3.995053,"twenty":-6.360054,"median":-3.925912,"eighty":-2.836115,"marketCap":682502800},{"date":"2020-07-10","current":-3.76648,"twenty":-6.20563,"median":-3.920401,"eighty":-2.836115,"marketCap":643454132},{"date":"2020-07-17","current":-3.577659,"twenty":-6.074107,"median":-3.914602,"eighty":-2.836115,"marketCap":611196537},{"date":"2020-07-24","current":-3.251009,"twenty":-6.017502,"median":-3.904066,"eighty":-2.836115,"marketCap":555392638},{"date":"2020-07-31","current":-3.05033,"twenty":-5.961909,"median":-3.899262,"eighty":-2.836115,"marketCap":521109142},{"date":"2020-08-07","current":-3.833517,"twenty":-5.803558,"median":-3.88708,"eighty":-2.836115,"marketCap":642815553},{"date":"2020-08-14","current":-4.058684,"twenty":-5.778569,"median":-3.883619,"eighty":-2.836115,"marketCap":680572242},{"date":"2020-08-21","current":-4.616616,"twenty":-5.728914,"median":-3.883619,"eighty":-2.836115,"marketCap":774127995},{"date":"2020-08-28","current":-4.682255,"twenty":-5.703675,"median":-3.883619,"eighty":-2.836115,"marketCap":785134554},{"date":"2020-09-04","current":-4.28842,"twenty":-5.641208,"median":-3.883619,"eighty":-2.836115,"marketCap":719095199},{"date":"2020-09-11","current":-5.458984,"twenty":-5.59687,"median":-3.883619,"eighty":-2.836115,"marketCap":915378838},{"date":"2020-09-18","current":-5.666841,"twenty":-5.580748,"median":-3.883619,"eighty":-2.836115,"marketCap":950232942},{"date":"2020-09-25","current":-4.397819,"twenty":-5.547903,"median":-3.883619,"eighty":-2.836115,"marketCap":737439465},{"date":"2020-10-02","current":-4.244661,"twenty":-5.495435,"median":-3.883619,"eighty":-2.836115,"marketCap":711757493},{"date":"2020-10-09","current":-4.758834,"twenty":-5.461992,"median":-3.883619,"eighty":-2.836115,"marketCap":797975540},{"date":"2020-10-16","current":-4.791653,"twenty":-5.365446,"median":-3.883619,"eighty":-2.836115,"marketCap":803478820},{"date":"2020-10-23","current":-4.3103,"twenty":-5.305659,"median":-3.883619,"eighty":-2.836115,"marketCap":722764052},{"date":"2020-10-30","current":-3.904566,"twenty":-5.275281,"median":-3.883619,"eighty":-2.836115,"marketCap":676903389},{"date":"2020-11-06","current":-4.042125,"twenty":-5.237757,"median":-3.883619,"eighty":-2.836115,"marketCap":700750934},{"date":"2020-11-13","current":-4.157,"twenty":-5.209217,"median":-3.883619,"eighty":-2.836115,"marketCap":720665850},{"date":"2020-11-20","current":-4.003443,"twenty":-5.16977,"median":-3.883619,"eighty":-2.836115,"marketCap":694044948},{"date":"2020-11-27","current":-4.069253,"twenty":-5.098028,"median":-3.882271,"eighty":-2.836115,"marketCap":705453906},{"date":"2020-12-04","current":-3.652457,"twenty":-5.035113,"median":-3.877463,"eighty":-2.836115,"marketCap":633197172},{"date":"2020-12-11","current":-3.773108,"twenty":-4.962022,"median":-3.868056,"eighty":-2.836115,"marketCap":654113595},{"date":"2020-12-18","current":-3.89376,"twenty":-4.933901,"median":-3.868056,"eighty":-2.836115,"marketCap":675030018},{"date":"2020-12-24","current":-3.718267,"twenty":-4.90425,"median":-3.858772,"eighty":-2.836115,"marketCap":644606130},{"date":"2020-12-31","current":-3.487931,"twenty":-4.865776,"median":-3.849295,"eighty":-2.836115,"marketCap":604674777},{"date":"2021-01-08","current":-3.56471,"twenty":-4.812294,"median":-3.840318,"eighty":-2.836115,"marketCap":617985228},{"date":"2021-01-15","current":-3.674393,"twenty":-4.783817,"median":-3.832242,"eighty":-2.836115,"marketCap":637000158},{"date":"2021-01-22","current":-3.773108,"twenty":-4.773466,"median":-3.826602,"eighty":-2.836115,"marketCap":654113595},{"date":"2021-01-29","current":-4.036348,"twenty":-4.754632,"median":-3.826602,"eighty":-2.836115,"marketCap":699749427},{"date":"2021-02-05","current":-5.681599,"twenty":-4.730955,"median":-3.826602,"eighty":-2.836115,"marketCap":984973379},{"date":"2021-02-12","current":-5.089309,"twenty":-4.730955,"median":-3.826602,"eighty":-2.836115,"marketCap":882292756},{"date":"2021-02-19","current":-4.913815,"twenty":-4.730955,"median":-3.826602,"eighty":-2.836115,"marketCap":851868868},{"date":"2021-02-26","current":-4.387335,"twenty":-4.697581,"median":-3.826602,"eighty":-2.836115,"marketCap":760597204},{"date":"2021-03-05","current":-3.509868,"twenty":-4.671003,"median":-3.822098,"eighty":-2.831819,"marketCap":608477763},{"date":"2021-03-12","current":-3.63052,"twenty":-4.639385,"median":-3.81323,"eighty":-2.831819,"marketCap":629394186},{"date":"2021-03-19","current":-3.507328,"twenty":-4.627212,"median":-3.795494,"eighty":-2.831819,"marketCap":634524808},{"date":"2021-03-26","current":-3.224479,"twenty":-4.614849,"median":-3.790531,"eighty":-2.836115,"marketCap":583353452},{"date":"2021-04-01","current":-3.247107,"twenty":-4.602401,"median":-3.773042,"eighty":-2.836115,"marketCap":587447161},{"date":"2021-04-09","current":-3.150939,"twenty":-4.594045,"median":-3.76214,"eighty":-2.831819,"marketCap":570048900},{"date":"2021-04-16","current":-2.964258,"twenty":-4.583225,"median":-3.751172,"eighty":-2.831819,"marketCap":536275805},{"date":"2021-04-23","current":-3.450759,"twenty":-4.561481,"median":-3.742286,"eighty":-2.831819,"marketCap":624290537},{"date":"2021-04-30","current":-3.799279,"twenty":-4.547596,"median":-3.732192,"eighty":-2.831819,"marketCap":687342717},{"date":"2021-05-07","current":-3.595749,"twenty":-4.534042,"median":-3.718267,"eighty":-2.831819,"marketCap":682893897},{"date":"2021-05-14","current":-3.78315,"twenty":-4.517345,"median":-3.712607,"eighty":-2.831819,"marketCap":718484459},{"date":"2021-05-21","current":-4.907553,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":932027827},{"date":"2021-05-28","current":-4.989541,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":947598698},{"date":"2021-06-04","current":-4.720153,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":896437266},{"date":"2021-06-11","current":-6.067095,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1152244426},{"date":"2021-06-18","current":-6.160795,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1170039707},{"date":"2021-06-25","current":-6.289633,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1194508218},{"date":"2021-07-02","current":-6.465321,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1227874369},{"date":"2021-07-09","current":-6.605871,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1254567290},{"date":"2021-07-16","current":-6.313058,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1198957038},{"date":"2021-07-23","current":-6.582446,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1250118470},{"date":"2021-07-30","current":-6.067095,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1152244426},{"date":"2021-08-06","current":-6.594159,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1252342880},{"date":"2021-08-13","current":-6.351279,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1433655066},{"date":"2021-08-20","current":-6.248006,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1410343602},{"date":"2021-08-27","current":-6.464879,"twenty":-4.512426,"median":-3.712607,"eighty":-2.831819,"marketCap":1459297677},{"date":"2021-09-03","current":-6.289315,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1419668188},{"date":"2021-09-10","current":-6.712733,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1515245192},{"date":"2021-09-17","current":-6.020806,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1359058380},{"date":"2021-09-24","current":-6.093097,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1375376405},{"date":"2021-10-01","current":-5.494114,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1240169911},{"date":"2021-10-08","current":-5.907205,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1333415769},{"date":"2021-10-15","current":-5.483787,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1237838764},{"date":"2021-10-22","current":-4.14124,"twenty":-4.510274,"median":-3.714145,"eighty":-2.836115,"marketCap":934789726},{"date":"2021-10-29","current":-3.965676,"twenty":-4.491197,"median":-3.714145,"eighty":-2.836115,"marketCap":895160236},{"date":"2021-11-05","current":-4.296149,"twenty":-4.50337,"median":-3.720603,"eighty":-2.836115,"marketCap":969756923},{"date":"2021-11-12","current":250.504017,"twenty":-4.492661,"median":-3.714145,"eighty":-2.767971,"marketCap":996504978},{"date":"2021-11-19","current":225.324489,"twenty":-4.480962,"median":-3.706852,"eighty":-2.716856,"marketCap":896340818},{"date":"2021-11-26","current":208.538138,"twenty":-4.480962,"median":-3.702346,"eighty":-2.673681,"marketCap":829564711},{"date":"2021-12-03","current":188.523641,"twenty":-4.480962,"median":-3.699858,"eighty":-2.645398,"marketCap":749947045},{"date":"2021-12-10","current":207.892509,"twenty":-4.480962,"median":-3.687712,"eighty":-2.594402,"marketCap":826996399},{"date":"2021-12-17","current":229.843891,"twenty":-4.480962,"median":-3.681489,"eighty":-2.55596,"marketCap":914319000},{"date":"2021-12-23","current":231.135149,"twenty":-4.480962,"median":-3.675884,"eighty":-2.518274,"marketCap":919455624},{"date":"2021-12-31","current":207.892509,"twenty":-4.480962,"median":-3.670231,"eighty":-2.488017,"marketCap":826996399},{"date":"2022-01-07","current":193.043044,"twenty":-4.478774,"median":-3.656664,"eighty":-2.484485,"marketCap":767925228},{"date":"2022-01-14","current":196.916817,"twenty":-4.478774,"median":-3.656664,"eighty":-2.460584,"marketCap":783335099},{"date":"2022-01-21","current":173.028548,"twenty":-4.478774,"median":-3.656664,"eighty":-2.442206,"marketCap":688307562},{"date":"2022-01-28","current":169.800403,"twenty":-4.476586,"median":-3.655673,"eighty":-2.416994,"marketCap":675466003},{"date":"2022-02-04","current":154.305309,"twenty":-4.476586,"median":-3.654546,"eighty":-2.368992,"marketCap":613826520},{"date":"2022-02-11","current":157.533454,"twenty":-4.476586,"median":-3.646266,"eighty":-2.309108,"marketCap":626668079},{"date":"2022-02-18","current":164.635372,"twenty":-4.473257,"median":-3.633585,"eighty":-2.287512,"marketCap":654919509},{"date":"2022-02-25","current":172.382919,"twenty":-4.472972,"median":-3.627385,"eighty":-2.273796,"marketCap":685739250},{"date":"2022-03-04","current":-31.276341,"twenty":-4.487372,"median":-3.624232,"eighty":-2.265661,"marketCap":748317732},{"date":"2022-03-11","current":-30.201553,"twenty":-4.515269,"median":-3.624232,"eighty":-2.265661,"marketCap":722602346},{"date":"2022-03-18","current":-31.813735,"twenty":-4.534668,"median":-3.624232,"eighty":-2.265661,"marketCap":761175425},{"date":"2022-03-25","current":-29.019285,"twenty":-4.545222,"median":-3.624232,"eighty":-2.265661,"marketCap":694315422},{"date":"2022-04-01","current":-27.622061,"twenty":-4.554265,"median":-3.624232,"eighty":-2.265661,"marketCap":660885420},{"date":"2022-04-08","current":-25.687441,"twenty":-4.583796,"median":-3.632439,"eighty":-2.265661,"marketCap":614597725},{"date":"2022-04-14","current":-25.150047,"twenty":-4.591972,"median":-3.639532,"eighty":-2.265661,"marketCap":601740032},{"date":"2022-04-22","current":-22.355598,"twenty":-4.602401,"median":-3.656664,"eighty":-2.265661,"marketCap":534880028},{"date":"2022-04-29","current":-20.898026,"twenty":-4.613626,"median":-3.662921,"eighty":-2.265661,"marketCap":500006178},{"date":"2022-05-06","current":-18.864705,"twenty":-4.627212,"median":-3.670231,"eighty":-2.265661,"marketCap":451356928},{"date":"2022-05-13","current":-23.781378,"twenty":-4.638718,"median":-3.674393,"eighty":-2.265661,"marketCap":441715308},{"date":"2022-05-20","current":-22.90599,"twenty":-4.670065,"median":-3.690098,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-05-27","current":-23.489582,"twenty":-4.693902,"median":-3.704311,"eighty":-2.265661,"marketCap":436295489},{"date":"2022-06-03","current":-24.510868,"twenty":-4.720153,"median":-3.714507,"eighty":-2.265661,"marketCap":455264858},{"date":"2022-06-10","current":-21.301111,"twenty":-4.748522,"median":-3.733485,"eighty":-2.265661,"marketCap":395646841},{"date":"2022-06-17","current":-22.90599,"twenty":-4.769115,"median":-3.74907,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-06-24","current":-28.934653,"twenty":-4.783709,"median":-3.750097,"eighty":-2.26134,"marketCap":537432248},{"date":"2022-07-01","current":-29.848379,"twenty":-4.814658,"median":-3.750097,"eighty":-2.26134,"marketCap":554403792},{"date":"2022-07-08","current":-41.269953,"twenty":-4.847014,"median":-3.750097,"eighty":-2.26134,"marketCap":766548101},{"date":"2022-07-15","current":-43.858843,"twenty":-4.889306,"median":-3.750097,"eighty":-2.26134,"marketCap":814634144},{"date":"2022-07-22","current":-40.508514,"twenty":-4.895841,"median":-3.750097,"eighty":-2.26134,"marketCap":752405147},{"date":"2022-07-29","current":-39.290213,"twenty":-4.909329,"median":-3.750097,"eighty":-2.26134,"marketCap":729776421},{"date":"2022-08-05","current":-40.356227,"twenty":-4.945769,"median":-3.750097,"eighty":-2.26134,"marketCap":749576556},{"date":"2022-08-12","current":45.998677,"twenty":-4.954877,"median":-3.740203,"eighty":-2.241781,"marketCap":840993818},{"date":"2022-08-19","current":43.210879,"twenty":-4.954877,"median":-3.718267,"eighty":-2.228928,"marketCap":790024496},{"date":"2022-08-26","current":41.352346,"twenty":-4.954877,"median":-3.706852,"eighty":-2.208814,"marketCap":756044948},{"date":"2022-09-02","current":39.803569,"twenty":-4.954877,"median":-3.693851,"eighty":-2.187438,"marketCap":727728658},{"date":"2022-09-09","current":41.662102,"twenty":-4.954877,"median":-3.677376,"eighty":-2.178074,"marketCap":761708206},{"date":"2022-09-16","current":36.241382,"twenty":-4.954877,"median":-3.663474,"eighty":-2.143769,"marketCap":662601190},{"date":"2022-09-23","current":32.98895,"twenty":-4.954877,"median":-3.652457,"eighty":-2.114419,"marketCap":603136981},{"date":"2022-09-30","current":31.749929,"twenty":-4.935664,"median":-3.633097,"eighty":-2.043977,"marketCap":580483949},{"date":"2022-10-07","current":41.507224,"twenty":-4.900526,"median":-3.619552,"eighty":-2.004987,"marketCap":758876577},{"date":"2022-10-14","current":37.790159,"twenty":-4.854232,"median":-3.602328,"eighty":-1.947842,"marketCap":690917480},{"date":"2022-10-21","current":40.887713,"twenty":-4.818365,"median":-3.587597,"eighty":-1.883135,"marketCap":747550061},{"date":"2022-10-28","current":39.493814,"twenty":-4.818365,"median":-3.577659,"eighty":-1.827749,"marketCap":722065400},{"date":"2022-11-04","current":37.790159,"twenty":-4.818365,"median":-3.57269,"eighty":-1.797631,"marketCap":690917480},{"date":"2022-11-11","current":-3.566927,"twenty":-4.818365,"median":-3.572342,"eighty":-1.787835,"marketCap":765077329},{"date":"2022-11-18","current":-4.348525,"twenty":-4.818365,"median":-3.575678,"eighty":-1.787835,"marketCap":932723756},{"date":"2022-11-25","current":-3.993253,"twenty":-4.818365,"median":-3.586647,"eighty":-1.787835,"marketCap":856520834},{"date":"2022-12-02","current":-4.220627,"twenty":-4.818365,"median":-3.595749,"eighty":-1.787835,"marketCap":905290704},{"date":"2022-12-09","current":-3.439029,"twenty":-4.818365,"median":-3.602328,"eighty":-1.787835,"marketCap":737644277},{"date":"2022-12-16","current":-3.396397,"twenty":-4.818365,"median":-3.609154,"eighty":-1.787835,"marketCap":728499927},{"date":"2022-12-23","current":-3.481662,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":746788628},{"date":"2022-12-30","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-06","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-13","current":-4.192205,"twenty":-4.818365,"median":-3.630887,"eighty":-1.787835,"marketCap":899194470},{"date":"2023-01-20","current":-3.836934,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":822991549},{"date":"2023-01-27","current":-3.737457,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":801654731},{"date":"2023-02-03","current":-3.652192,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":783366030},{"date":"2023-02-10","current":-3.154812,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":676681940},{"date":"2023-02-17","current":-3.112179,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":667537590},{"date":"2023-02-24","current":-2.813751,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":603527136},{"date":"2023-03-03","current":-2.78533,"twenty":-4.787082,"median":-3.623771,"eighty":-1.787835,"marketCap":597430902},{"date":"2023-03-10","current":-2.13163,"twenty":-4.761022,"median":-3.609154,"eighty":-1.787835,"marketCap":457217527},{"date":"2023-03-17","current":-2.568557,"twenty":-4.722497,"median":-3.595749,"eighty":-1.787835,"marketCap":565272567},{"date":"2023-03-24","current":-2.251264,"twenty":-4.720153,"median":-3.586647,"eighty":-1.787835,"marketCap":495444779},{"date":"2023-03-31","current":-2.296592,"twenty":-4.720153,"median":-3.576669,"eighty":-1.787835,"marketCap":505420178},{"date":"2023-04-06","current":-2.190828,"twenty":-4.720153,"median":-3.573126,"eighty":-1.787835,"marketCap":482144248},{"date":"2023-04-14","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-04-21","current":-2.538338,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":558622302},{"date":"2023-04-28","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-05-05","current":-2.375309,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":522743683},{"date":"2023-05-12","current":-1.990022,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":478327553},{"date":"2023-05-18","current":-2.136839,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":512847659},{"date":"2023-05-26","current":-2.049621,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":491915102},{"date":"2023-06-02","current":-2.311274,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":554712774},{"date":"2023-06-08","current":-2.732828,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":655886802},{"date":"2023-06-16","current":-2.631073,"twenty":-4.720153,"median":-3.570015,"eighty":-1.787835,"marketCap":631465485},{"date":"2023-06-23","current":-2.587464,"twenty":-4.720153,"median":-3.572309,"eighty":-1.812326,"marketCap":620999207},{"date":"2023-06-30","current":-2.427565,"twenty":-4.720153,"median":-3.572309,"eighty":-1.898861,"marketCap":582622851},{"date":"2023-07-07","current":-2.282202,"twenty":-4.720153,"median":-3.572325,"eighty":-1.952741,"marketCap":547735255},{"date":"2023-07-14","current":-2.689219,"twenty":-4.720153,"median":-3.572342,"eighty":-1.990022,"marketCap":645420524},{"date":"2023-07-21","current":-2.383956,"twenty":-4.721325,"median":-3.572516,"eighty":-2.032983,"marketCap":572156572},{"date":"2023-07-28","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.049401,"marketCap":505870140},{"date":"2023-08-04","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":505870140},{"date":"2023-08-11","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-18","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-25","current":-1.922536,"twenty":-4.722497,"median":-3.57269,"eighty":-2.122302,"marketCap":504831008},{"date":"2023-09-01","current":-1.994812,"twenty":-4.72367,"median":-3.573126,"eighty":-2.122302,"marketCap":523809618},{"date":"2023-09-06","current":-1.85026,"twenty":-4.724842,"median":-3.573563,"eighty":-2.122823,"marketCap":485852399},{"date":"2023-09-15","current":-1.87917,"twenty":-4.730669,"median":-3.575678,"eighty":-2.125954,"marketCap":493443843},{"date":"2023-09-21","current":-1.734619,"twenty":-4.735324,"median":-3.575678,"eighty":-2.126721,"marketCap":455486624},{"date":"2023-09-27","current":-1.662343,"twenty":-4.744635,"median":-3.575678,"eighty":-2.131737,"marketCap":436508015},{"date":"2023-10-05","current":-1.459971,"twenty":-4.751199,"median":-3.576669,"eighty":-2.134128,"marketCap":383367908},{"date":"2023-10-13","current":-1.474426,"twenty":-4.755016,"median":-3.579398,"eighty":-2.135507,"marketCap":387163630},{"date":"2023-10-20","current":-1.392032,"twenty":-4.756925,"median":-3.581138,"eighty":-2.137245,"marketCap":365528016},{"date":"2023-10-27","current":-1.170868,"twenty":-4.758834,"median":-3.584493,"eighty":-2.147035,"marketCap":307453471},{"date":"2023-11-03","current":-1.228688,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":322636358},{"date":"2023-11-10","current":-1.049912,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":285969685},{"date":"2023-11-17","current":-0.987001,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":267046829},{"date":"2023-11-24","current":-0.97276,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":263193725},{"date":"2023-12-01","current":-1.095712,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":296460130},{"date":"2023-12-08","current":-1.142806,"twenty":-4.758834,"median":-3.584493,"eighty":-2.143769,"marketCap":309202079},{"date":"2023-12-15","current":-1.073293,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":290394352},{"date":"2023-12-22","current":-1.096417,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":296650878},{"date":"2023-12-29","current":-1.142101,"twenty":-4.758834,"median":-3.584493,"eighty":-2.135507,"marketCap":309011331},{"date":"2024-01-05","current":-1.095148,"twenty":-4.758834,"median":-3.58557,"eighty":-2.134619,"marketCap":296307532},{"date":"2024-01-12","current":-1.007446,"twenty":-4.758834,"median":-3.58557,"eighty":-2.125169,"marketCap":272578514},{"date":"2024-01-19","current":-0.794394,"twenty":-4.758834,"median":-3.586647,"eighty":-2.107766,"marketCap":214934548},{"date":"2024-01-26","current":-0.845719,"twenty":-4.758834,"median":-3.58557,"eighty":-2.075999,"marketCap":228820983},{"date":"2024-02-02","current":-0.895633,"twenty":-4.758834,"median":-3.58557,"eighty":-2.035084,"marketCap":242325923},{"date":"2024-02-09","current":-0.983194,"twenty":-4.758834,"median":-3.58557,"eighty":-1.99098,"marketCap":266016791},{"date":"2024-02-16","current":-0.964752,"twenty":-4.758834,"median":-3.58557,"eighty":-1.939882,"marketCap":261027212},{"date":"2024-02-23","current":-0.996035,"twenty":-4.758834,"median":-3.58557,"eighty":-1.896517,"marketCap":269491233},{"date":"2024-03-01","current":-0.988965,"twenty":-4.758834,"median":-3.584493,"eighty":-1.85026,"marketCap":267578233},{"date":"2024-03-08","current":-1.035018,"twenty":-4.758834,"median":-3.584493,"eighty":-1.792843,"marketCap":280038593},{"date":"2024-03-15","current":-0.975875,"twenty":-4.758834,"median":-3.584493,"eighty":-1.65367,"marketCap":251226366},{"date":"2024-03-22","current":-0.958317,"twenty":-4.758834,"median":-3.584493,"eighty":-1.538029,"marketCap":235516863},{"date":"2024-03-28","current":-0.94843,"twenty":-4.758834,"median":-3.584493,"eighty":-1.484545,"marketCap":233087127},{"date":"2024-04-05","current":-0.862349,"twenty":-4.758834,"median":-3.58557,"eighty":-1.295732,"marketCap":211931663},{"date":"2024-04-12","current":-0.755983,"twenty":-4.758834,"median":-3.58557,"eighty":-1.171601,"marketCap":185791046},{"date":"2024-04-19","current":-0.423589,"twenty":-4.758834,"median":-3.58557,"eighty":-1.150283,"marketCap":104101634},{"date":"2024-04-26","current":-0.707402,"twenty":-4.758834,"median":-3.584493,"eighty":-1.141509,"marketCap":173851824},{"date":"2024-05-03","current":-1.069542,"twenty":-4.758834,"median":-3.584493,"eighty":-1.12724,"marketCap":262851728},{"date":"2024-05-10","current":-1.028064,"twenty":-4.758834,"median":-3.584493,"eighty":-1.10327,"marketCap":246111338},{"date":"2024-05-17","current":-0.921047,"twenty":-4.758834,"median":-3.575678,"eighty":-1.095374,"marketCap":220492240},{"date":"2024-05-24","current":-1.083327,"twenty":-4.758834,"median":-3.572309,"eighty":-1.076226,"marketCap":259340873},{"date":"2024-05-31","current":-1.325431,"twenty":-4.758834,"median":-3.56471,"eighty":-1.076226,"marketCap":317298833},{"date":"2024-06-07","current":-1.452623,"twenty":-4.758834,"median":-3.552584,"eighty":-1.076226,"marketCap":347747762},{"date":"2024-06-14","current":-1.4035,"twenty":-4.758834,"median":-3.542773,"eighty":-1.074759,"marketCap":335988176},{"date":"2024-06-21","current":-1.190344,"twenty":-4.758834,"median":-3.537907,"eighty":-1.073293,"marketCap":284959971},{"date":"2024-06-28","current":-1.238589,"twenty":-4.762116,"median":-3.528963,"eighty":-1.072785,"marketCap":296509565},{"date":"2024-07-05","current":-1.274554,"twenty":-4.762116,"median":-3.51515,"eighty":-1.072785,"marketCap":305119262},{"date":"2024-07-12","current":-1.349992,"twenty":-4.762116,"median":-3.508598,"eighty":-1.072785,"marketCap":323178626},{"date":"2024-07-15","current":-1.368413,"twenty":-4.762116,"median":-3.503383,"eighty":-1.072785,"marketCap":327588471},{"date":"2024-08-02","current":-0.523681,"twenty":-4.777562,"median":-3.481662,"eighty":-1.070617,"marketCap":125365588},{"date":"2024-08-09","current":-0.509715,"twenty":-4.777562,"median":-3.475136,"eighty":-1.052035,"marketCap":113899848},{"date":"2024-08-16","current":-0.499096,"twenty":-4.777562,"median":-3.475136,"eighty":-1.0353,"marketCap":111526934},{"date":"2024-08-23","current":-0.528057,"twenty":-4.777562,"median":-3.467451,"eighty":-1.011394,"marketCap":117998517},{"date":"2024-08-30","current":-0.481719,"twenty":-4.777562,"median":-3.467451,"eighty":-1.002749,"marketCap":107643985},{"date":"2024-09-06","current":-0.482684,"twenty":-4.777562,"median":-3.465995,"eighty":-0.993799,"marketCap":107859705},{"date":"2024-09-13","current":-0.572464,"twenty":-4.777562,"median":-3.432608,"eighty":-0.988904,"marketCap":127921610},{"date":"2024-09-20","current":-0.578256,"twenty":-4.777562,"median":-3.410608,"eighty":-0.985676,"marketCap":129215926},{"date":"2024-09-27","current":-0.499096,"twenty":-4.777562,"median":-3.383717,"eighty":-0.975109,"marketCap":111526934},{"date":"2024-10-04","current":-0.440208,"twenty":-4.777562,"median":-3.383717,"eighty":-0.972752,"marketCap":98368050},{"date":"2024-10-11","current":-0.410282,"twenty":-4.777562,"median":-3.383717,"eighty":-0.959969,"marketCap":91680749},{"date":"2024-10-18","current":-0.441174,"twenty":-4.777562,"median":-3.383717,"eighty":-0.952469,"marketCap":98583770},{"date":"2024-10-25","current":-0.425728,"twenty":-4.777562,"median":-3.383717,"eighty":-0.940321,"marketCap":95132259},{"date":"2024-10-31","current":-0.423797,"twenty":-4.777562,"median":-3.383717,"eighty":-0.930994,"marketCap":94700820},{"date":"2024-11-08","current":-0.37939,"twenty":-4.777562,"median":-3.374713,"eighty":-0.91572,"marketCap":84777728},{"date":"2024-11-15","current":-0.285452,"twenty":-4.777562,"median":-3.303677,"eighty":-0.897325,"marketCap":64981233},{"date":"2024-11-22","current":-0.294727,"twenty":-4.761022,"median":-3.28271,"eighty":-0.869324,"marketCap":67092536},{"date":"2024-11-29","current":-0.352436,"twenty":-4.761022,"median":-3.252725,"eighty":-0.844647,"marketCap":80229537},{"date":"2024-12-06","current":-0.323581,"twenty":-4.761022,"median":-3.219896,"eighty":-0.822086,"marketCap":73661037},{"date":"2024-12-13","current":-0.317398,"twenty":-4.761022,"median":-3.168467,"eighty":-0.736551,"marketCap":72253501},{"date":"2024-12-20","current":-0.284422,"twenty":-4.761022,"median":-3.145635,"eighty":-0.595633,"marketCap":64746644},{"date":"2024-12-27","current":-0.289574,"twenty":-4.761022,"median":-3.106339,"eighty":-0.570147,"marketCap":65919590},{"date":"2025-01-03","current":-0.318429,"twenty":-4.761022,"median":-3.077193,"eighty":-0.552626,"marketCap":72488090},{"date":"2025-01-10","current":-0.350375,"twenty":-4.762116,"median":-3.05033,"eighty":-0.532191,"marketCap":79760358},{"date":"2025-01-17","current":-0.324612,"twenty":-4.762116,"median":-3.026485,"eighty":-0.512032,"marketCap":73895626},{"date":"2025-01-24","current":-0.387473,"twenty":-4.762116,"median":-2.980497,"eighty":-0.499868,"marketCap":88205573},{"date":"2025-01-31","current":-0.364802,"twenty":-4.762116,"median":-2.925709,"eighty":-0.495234,"marketCap":83044608},{"date":"2025-02-07","current":-0.385412,"twenty":-4.762116,"median":-2.870595,"eighty":-0.491533,"marketCap":87736394},{"date":"2025-02-14","current":-0.36068,"twenty":-4.762116,"median":-2.79954,"eighty":-0.479402,"marketCap":82106251},{"date":"2025-02-21","current":-0.355527,"twenty":-4.758834,"median":-2.764976,"eighty":-0.472606,"marketCap":80933305},{"date":"2025-02-28","current":-0.294727,"twenty":-4.758834,"median":-2.732828,"eighty":-0.45783,"marketCap":67092536},{"date":"2025-03-07","current":-0.242171,"twenty":-4.758834,"median":-2.711023,"eighty":-0.44909,"marketCap":55128483},{"date":"2025-03-14","current":-0.172611,"twenty":-4.758834,"median":-2.681951,"eighty":-0.441367,"marketCap":39293706},{"date":"2025-03-21","current":-0.186019,"twenty":-4.758834,"median":-2.616264,"eighty":-0.433644,"marketCap":42265764},{"date":"2025-03-28","current":-0.184905,"twenty":-4.758834,"median":-2.568557,"eighty":-0.424183,"marketCap":42012676},{"date":"2025-04-04","current":-0.178222,"twenty":-4.758834,"median":-2.531287,"eighty":-0.402997,"marketCap":40494145},{"date":"2025-04-11","current":-0.18045,"twenty":-4.758834,"median":-2.488661,"eighty":-0.391222,"marketCap":41000322},{"date":"2025-04-17","current":-0.183791,"twenty":-4.758834,"median":-2.484485,"eighty":-0.381387,"marketCap":41759587}],"updateTime":1745205602985}}}